Cisplatin-based combination therapies: Their efficacy with a focus on ginsenosides co-administration

Cisplatin, a frequently prescribed chemotherapeutic agent, serves as a clinically therapeutic strategy for a broad range of malignancies. Its primary mode of action centers around interference with DNA replication and RNA transcription, thereby inducing apoptosis in cancer cells. Nevertheless, the c...

Descripción completa

Detalles Bibliográficos

Autores principales:	Keke Li, Jiwen Li, Zhongyu Li, Lei Men, Haibin Zuo, Xiaojie Gong
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2024-05-01
Colección:	Pharmacological Research
Materias:	Ginsenoside Cisplatin Anticancer Combined Therapy Molecular Mechanism
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S1043661824001191
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!